These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24658683)

  • 41. Impact of aging on cardiac sympathetic innervation measured by
    Rengo G; Pagano G; Vitale DF; Formisano R; Komici K; Petraglia L; Parisi V; Femminella GD; de Lucia C; Paolillo S; Cannavo A; Attena E; Pellegrino T; Dellegrottaglie S; Memmi A; Trimarco B; Cuocolo A; Filardi PP; Leosco D; Ferrara N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2392-2400. PubMed ID: 27287990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Int J Cardiol; 2013 Jul; 167(1):244-9. PubMed ID: 22245478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Int Heart J; 2018 Jan; 59(1):120-125. PubMed ID: 29269711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.
    Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T
    Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Koyama Y; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Okada A; Takahashi K; Kubota I
    Ann Nucl Med; 2005 Oct; 19(7):535-40. PubMed ID: 16363617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects.
    Cargill RI; Lipworth BJ
    Chest; 1996 Nov; 110(5):1220-5. PubMed ID: 8915224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
    Kasama S; Furuya M; Toyama T; Ichikawa S; Kurabayashi M
    Eur Heart J; 2008 Jun; 29(12):1485-94. PubMed ID: 18490430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.
    Toyama T; Hoshizaki H; Kasama S; Miyaishi Y; Kan H; Yamashita E; Kawaguti R; Adachi H; Ohsima S
    J Nucl Cardiol; 2017 Dec; 24(6):1926-1937. PubMed ID: 27387522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral factors in patients with dilated cardiomyopathy.
    Matsui T; Tsutamoto T; Kinoshita M
    Jpn Circ J; 2001 Dec; 65(12):1041-6. PubMed ID: 11767995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of
    Tokuda Y; Sakakibara M; Yoshinaga K; Yamada S; Kamiya K; Asakawa N; Yoshitani T; Noguchi K; Manabe O; Tamaki N; Tsutsui H
    J Nucl Cardiol; 2019 Aug; 26(4):1079-1089. PubMed ID: 29181786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure.
    Tsuchida T; Fukuma N; Oikawa K; Kato K; Kato Y; Takano T; Kumita S
    J Nippon Med Sch; 2007 Apr; 74(2):114-22. PubMed ID: 17507788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
    Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T
    Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.